POTENTIAL TARGETS FROM HUMAN (RESULTS FROM SUB-STRUCTURAL SIMILARITY SEARCHES)
1) User may click on the DrReposER ID (the second column) to get information on the binding sites and drug molecule.
2) Click View (the second last column) to view matched residues and superposition in the NGL viewer (upper right part).
3) User may also click on the Dock (the last column) to get script for molecular docking in UCSF Chimera through AutoDock Vina.


DrReposER ID / Desc. Hit
PDBID
Hit
Macromolecule
Res.
Matches
Interface HETATM RMSD Seq.
Identity (%)
View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5F8Y_A_X6XA201_1
(GALNAC/GAL-SPECIFIC
LECTIN)
2akz GAMMA ENOLASE
(Homo
sapiens)
5 / 9ASN A 150
HIS A 157
GLY A 154
GLY A 155
ASP A 208
None
PO4  A 442 (-4.1A)
None
None
None
1.44A15.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5F8Y_A_X6XA201_1
(GALNAC/GAL-SPECIFIC
LECTIN)
3b97 ALPHA-ENOLASE
(Homo
sapiens)
5 / 9ASN A 150
HIS A 157
GLY A 154
GLY A 155
ASP A 208
None
SO4  A 436 (-4.1A)
None
None
None
1.41A15.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5F8Y_A_X6XA202_1
(GALNAC/GAL-SPECIFIC
LECTIN)
1xfb ALDOLASE C
(Homo
sapiens)
5 / 8GLU A 190
GLY A 273
GLY A 274
ASP A 194
HIS A 238
None
1.43A16.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5F8Y_A_X6XA202_1
(GALNAC/GAL-SPECIFIC
LECTIN)
2frg TREM-LIKE
TRANSCRIPT-1
(Homo
sapiens)
4 / 8GLY P  84
GLY P  85
VAL P  67
ASP P  44
None
0.77A20.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5F8Y_A_X6XA202_1
(GALNAC/GAL-SPECIFIC
LECTIN)
2qyk CYCLIC AMP-SPECIFIC
PHOSPHODIESTERASE
HSPDE4A10
(Homo
sapiens)
5 / 8GLU A 551
VAL A 369
HIS A 372
ASP A 413
HIS A 445
None
None
NPV  A   3 (-4.6A)
MG  A   2 ( 2.6A)
None
1.16A17.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5F8Y_A_X6XA202_1
(GALNAC/GAL-SPECIFIC
LECTIN)
2qym PHOSPHODIESTERASE 4C
(Homo
sapiens)
5 / 8GLU A 461
VAL A 279
HIS A 282
ASP A 323
HIS A 355
None
None
None
MG  A   2 ( 2.6A)
None
1.22A14.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5F8Y_A_X6XA202_1
(GALNAC/GAL-SPECIFIC
LECTIN)
2xmr PROTEIN NDRG2
(Homo
sapiens)
4 / 8HIS A 253
GLY A 132
VAL A 257
HIS A 186
None
0.75A19.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5F8Y_A_X6XA202_1
(GALNAC/GAL-SPECIFIC
LECTIN)
3b2r CGMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE
(Homo
sapiens)
5 / 8GLU A 785
GLY A 659
VAL A 610
HIS A 613
HIS A 684
None
None
None
VDN  A   1 (-4.3A)
None
1.30A16.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5F8Y_A_X6XA202_1
(GALNAC/GAL-SPECIFIC
LECTIN)
3g4g CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4D
(Homo
sapiens)
5 / 8GLU A 505
VAL A 323
HIS A 326
ASP A 367
HIS A 399
None
None
D71  A 901 (-4.5A)
MG  A 802 ( 2.7A)
None
1.20A18.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5F8Y_A_X6XA202_1
(GALNAC/GAL-SPECIFIC
LECTIN)
3o57 CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4B
(Homo
sapiens)
5 / 8GLU A 413
VAL A 231
HIS A 234
ASP A 275
HIS A 307
None
None
None
MG  A 504 ( 2.6A)
None
1.19A15.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5F8Y_A_X6XA202_1
(GALNAC/GAL-SPECIFIC
LECTIN)
3p11 RECEPTOR
TYROSINE-PROTEIN
KINASE ERBB-3
(Homo
sapiens)
4 / 8GLU A  63
GLY A 265
GLY A 264
VAL A  39
None
0.75A13.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5F8Y_A_X6XA202_1
(GALNAC/GAL-SPECIFIC
LECTIN)
3sl5 CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4D
(Homo
sapiens)
5 / 8GLU A 339
VAL A 157
HIS A 160
ASP A 201
HIS A 233
GLU  A 339 ( 0.5A)
VAL  A 157 ( 0.6A)
HIS  A 160 ( 1.0A)
ASP  A 201 ( 0.5A)
HIS  A 233 ( 1.0A)
1.31A16.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5F8Y_A_X6XA202_1
(GALNAC/GAL-SPECIFIC
LECTIN)
4leo RECEPTOR
TYROSINE-PROTEIN
KINASE ERBB-3
(Homo
sapiens)
4 / 8GLU C  63
GLY C 265
GLY C 264
VAL C  39
NAG  C 701 ( 4.7A)
None
None
None
0.79A12.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5F8Y_A_X6XA202_1
(GALNAC/GAL-SPECIFIC
LECTIN)
4wzi CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4B
(Homo
sapiens)
5 / 8GLU A 585
VAL A 403
HIS A 406
ASP A 447
HIS A 479
None
None
MG  A 804 ( 4.9A)
MG  A 804 ( 2.7A)
None
1.27A11.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5F8Y_A_X6XA202_1
(GALNAC/GAL-SPECIFIC
LECTIN)
5jzn SERINE/THREONINE-PRO
TEIN KINASE DCLK1
(Homo
sapiens)
5 / 8GLU A 557
GLY A 565
VAL A 632
ASP A 569
HIS A 503
None
1.41A17.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5F8Y_A_X6XA202_1
(GALNAC/GAL-SPECIFIC
LECTIN)
5la7 HEPARANASE
(Homo
sapiens)
4 / 8GLY A 350
GLY A 351
VAL A 384
ASP A 357
6S6  A 613 (-3.7A)
None
None
None
0.78A12.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5F8Y_A_X6XA202_1
(GALNAC/GAL-SPECIFIC
LECTIN)
5la7 HEPARANASE
(Homo
sapiens)
4 / 8GLY A 350
GLY A 351
VAL A 384
HIS A 392
6S6  A 613 (-3.7A)
None
None
None
0.73A12.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5F8Y_A_X6XA202_1
(GALNAC/GAL-SPECIFIC
LECTIN)
5ohj CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4B
(Homo
sapiens)
5 / 8GLU A 585
VAL A 403
HIS A 406
ASP A 447
HIS A 479
None
None
None
MG  A 700 ( 2.7A)
None
1.19A20.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5F8Y_A_X6XA202_1
(GALNAC/GAL-SPECIFIC
LECTIN)
5t43 LIPOCALIN-1
(Homo
sapiens)
4 / 8HIS A  84
GLY A  82
GLY A  81
VAL A  85
None
0.64A18.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5F8Y_A_X6XA202_1
(GALNAC/GAL-SPECIFIC
LECTIN)
5wh6 CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4D
(Homo
sapiens)
5 / 8GLU A 339
VAL A 157
HIS A 160
ASP A 201
HIS A 233
None
None
None
MG  A 603 ( 2.6A)
None
1.18Aundetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5F8Y_A_X6XA203_1
(GALNAC/GAL-SPECIFIC
LECTIN)
2akz GAMMA ENOLASE
(Homo
sapiens)
5 / 9HIS A 157
GLY A 154
GLY A 155
ASP A 208
ASN A 150
PO4  A 442 (-4.1A)
None
None
None
None
1.46A15.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5F8Y_A_X6XA203_1
(GALNAC/GAL-SPECIFIC
LECTIN)
3b97 ALPHA-ENOLASE
(Homo
sapiens)
5 / 9HIS A 157
GLY A 154
GLY A 155
ASP A 208
ASN A 150
SO4  A 436 (-4.1A)
None
None
None
None
1.43A15.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5F8Y_B_X6XB201_1
(GALNAC/GAL-SPECIFIC
LECTIN)
2frg TREM-LIKE
TRANSCRIPT-1
(Homo
sapiens)
4 / 8GLY P  84
GLY P  85
VAL P  67
ASP P  44
None
0.78A20.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5F8Y_B_X6XB201_1
(GALNAC/GAL-SPECIFIC
LECTIN)
2qyk CYCLIC AMP-SPECIFIC
PHOSPHODIESTERASE
HSPDE4A10
(Homo
sapiens)
5 / 8GLU A 551
VAL A 369
HIS A 372
ASP A 413
HIS A 445
None
None
NPV  A   3 (-4.6A)
MG  A   2 ( 2.6A)
None
1.18A17.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5F8Y_B_X6XB201_1
(GALNAC/GAL-SPECIFIC
LECTIN)
2qym PHOSPHODIESTERASE 4C
(Homo
sapiens)
5 / 8GLU A 461
VAL A 279
HIS A 282
ASP A 323
HIS A 355
None
None
None
MG  A   2 ( 2.6A)
None
1.24A14.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5F8Y_B_X6XB201_1
(GALNAC/GAL-SPECIFIC
LECTIN)
2xmr PROTEIN NDRG2
(Homo
sapiens)
4 / 8HIS A 253
GLY A 132
VAL A 257
HIS A 186
None
0.77A19.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5F8Y_B_X6XB201_1
(GALNAC/GAL-SPECIFIC
LECTIN)
3b2r CGMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE
(Homo
sapiens)
5 / 8GLU A 785
GLY A 659
VAL A 610
HIS A 613
HIS A 684
None
None
None
VDN  A   1 (-4.3A)
None
1.34A16.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5F8Y_B_X6XB201_1
(GALNAC/GAL-SPECIFIC
LECTIN)
3g4g CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4D
(Homo
sapiens)
5 / 8GLU A 505
VAL A 323
HIS A 326
ASP A 367
HIS A 399
None
None
D71  A 901 (-4.5A)
MG  A 802 ( 2.7A)
None
1.22A18.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5F8Y_B_X6XB201_1
(GALNAC/GAL-SPECIFIC
LECTIN)
3o57 CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4B
(Homo
sapiens)
5 / 8GLU A 413
VAL A 231
HIS A 234
ASP A 275
HIS A 307
None
None
None
MG  A 504 ( 2.6A)
None
1.21A15.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5F8Y_B_X6XB201_1
(GALNAC/GAL-SPECIFIC
LECTIN)
3p11 RECEPTOR
TYROSINE-PROTEIN
KINASE ERBB-3
(Homo
sapiens)
4 / 8GLU A  63
GLY A 265
GLY A 264
VAL A  39
None
0.78A13.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5F8Y_B_X6XB201_1
(GALNAC/GAL-SPECIFIC
LECTIN)
3sl5 CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4D
(Homo
sapiens)
5 / 8GLU A 339
VAL A 157
HIS A 160
ASP A 201
HIS A 233
GLU  A 339 ( 0.5A)
VAL  A 157 ( 0.6A)
HIS  A 160 ( 1.0A)
ASP  A 201 ( 0.5A)
HIS  A 233 ( 1.0A)
1.34A16.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5F8Y_B_X6XB201_1
(GALNAC/GAL-SPECIFIC
LECTIN)
4wzi CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4B
(Homo
sapiens)
5 / 8GLU A 585
VAL A 403
HIS A 406
ASP A 447
HIS A 479
None
None
MG  A 804 ( 4.9A)
MG  A 804 ( 2.7A)
None
1.29A11.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5F8Y_B_X6XB201_1
(GALNAC/GAL-SPECIFIC
LECTIN)
4ylj DUAL SPECIFICITY
TYROSINE-PHOSPHORYLA
TION-REGULATED
KINASE 1A
(Homo
sapiens)
4 / 8HIS A 444
GLY A 432
GLY A 433
HIS A 355
None
0.73A18.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5F8Y_B_X6XB201_1
(GALNAC/GAL-SPECIFIC
LECTIN)
5la7 HEPARANASE
(Homo
sapiens)
4 / 8GLY A 350
GLY A 351
VAL A 384
ASP A 357
6S6  A 613 (-3.7A)
None
None
None
0.76A12.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5F8Y_B_X6XB201_1
(GALNAC/GAL-SPECIFIC
LECTIN)
5la7 HEPARANASE
(Homo
sapiens)
4 / 8GLY A 350
GLY A 351
VAL A 384
HIS A 392
6S6  A 613 (-3.7A)
None
None
None
0.69A12.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5F8Y_B_X6XB201_1
(GALNAC/GAL-SPECIFIC
LECTIN)
5ohj CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4B
(Homo
sapiens)
5 / 8GLU A 585
VAL A 403
HIS A 406
ASP A 447
HIS A 479
None
None
None
MG  A 700 ( 2.7A)
None
1.21A20.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5F8Y_B_X6XB201_1
(GALNAC/GAL-SPECIFIC
LECTIN)
5t43 LIPOCALIN-1
(Homo
sapiens)
4 / 8HIS A  84
GLY A  82
GLY A  81
VAL A  85
None
0.68A18.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5F8Y_B_X6XB201_1
(GALNAC/GAL-SPECIFIC
LECTIN)
5wh6 CAMP-SPECIFIC
3',5'-CYCLIC
PHOSPHODIESTERASE 4D
(Homo
sapiens)
5 / 8GLU A 339
VAL A 157
HIS A 160
ASP A 201
HIS A 233
None
None
None
MG  A 603 ( 2.6A)
None
1.20Aundetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5F8Y_B_X6XB202_1
(GALNAC/GAL-SPECIFIC
LECTIN)
2akz GAMMA ENOLASE
(Homo
sapiens)
5 / 9HIS A 157
GLY A 154
GLY A 155
ASP A 208
ASN A 150
PO4  A 442 (-4.1A)
None
None
None
None
1.46A15.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5F8Y_B_X6XB202_1
(GALNAC/GAL-SPECIFIC
LECTIN)
3b97 ALPHA-ENOLASE
(Homo
sapiens)
5 / 9HIS A 157
GLY A 154
GLY A 155
ASP A 208
ASN A 150
SO4  A 436 (-4.1A)
None
None
None
None
1.43A15.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5F8Y_B_X6XB203_1
(GALNAC/GAL-SPECIFIC
LECTIN)
2akz GAMMA ENOLASE
(Homo
sapiens)
5 / 9ASN A 150
HIS A 157
GLY A 154
GLY A 155
ASP A 208
None
PO4  A 442 (-4.1A)
None
None
None
1.44A15.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5F8Y_B_X6XB203_1
(GALNAC/GAL-SPECIFIC
LECTIN)
3b97 ALPHA-ENOLASE
(Homo
sapiens)
5 / 9ASN A 150
HIS A 157
GLY A 154
GLY A 155
ASP A 208
None
SO4  A 436 (-4.1A)
None
None
None
1.41A15.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5KGJ_A_X6XA402_1
(PREDICTED
ACETYLTRANSFERASE)
1p22 F-BOX/WD-REPEAT
PROTEIN 1A
(Homo
sapiens)
4 / 5ARG A 251
TRP A 250
GLU A 247
ASP A 479
None
1.04A20.05